富血供子宫肌瘤(子宫平滑肌肿瘤)的超声特征及其与组织病理学的相关性
这项前瞻性观察研究纳入70例术前超声诊断为富血供子宫肌瘤(MUSA血流评分3或4分,伴环状及病灶内血流)并接受肌瘤剔除或子宫切除术的患者,将超声特征与最终组织学诊断进行相关性分析。组织学显示65例(92.9%)为良性病变,5例(7.1%)为恶性。恶性病变患者平均年龄显著高于良性病变患者(64.8±16.0岁 vs 42.4±5.1岁;P<0.001),病灶边界规则在良性病变中占64/65(98.5%)、恶性病变中占2/5(40%)(P<0.05),子宫内膜可见在良性病变中占55/65、恶性病变中占2/5(P=0.03)。
要点
- 富血供子宫肌瘤中恶性病变患者平均年龄显著高于良性病变患者(64.8±16.0岁 vs 42.4±5.1岁;P<0.001)。
- 病灶边界规则在良性病变中占64/65(98.5%),在恶性病变中占2/5(40%)(P<0.05)。
- 子宫内膜可见在良性病变中占55/65,在恶性病变中占2/5(P=0.03)。
核心结论
- 富血供子宫肌瘤的超声特征如环状及病灶内血流、囊性区域和病灶边界是鉴别诊断的重要参数,尤其当结合患者年龄时。
- 这些特征可能有助于术前区分典型肌瘤与良性变异及恶性病变,并筛选可能受益于保守治疗而非手术的患者。
研究设计与样本
- 前瞻性观察研究,纳入70例术前超声诊断为富血供子宫肌瘤(MUSA血流评分3或4分,伴环状及病灶内血流)并接受肌瘤剔除或子宫切除术的患者。
- 平均年龄46.5±11.4岁,13例(18.6%)为绝经后。
主要发现
- 组织学检查显示65例(92.9%)为良性病变,包括32例典型平滑肌瘤、29例平滑肌瘤变异和4例腺肌瘤。
- 5例(7.1%)为恶性病变,包括2例子宫肉瘤、1例平滑肌肉瘤、1例神经内分泌肿瘤和1例恶性潜能未定的子宫平滑肌肿瘤(STUMP)。
- 恶性病变患者平均年龄显著高于良性病变患者(64.8±16.0岁 vs 42.4±5.1岁;P<0.001),5例恶性病变患者中4例超过45岁。
- 囊性区域见于10/32(31.3%)典型平滑肌瘤、16/29(55.2%)平滑肌瘤变异、全部4例腺肌瘤以及STUMP和平滑肌肉瘤病例。
- 病灶边界规则在良性病变中占64/65(98.5%),在恶性病变中占2/5(40%)(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To correlate the ultrasound appearance of highly vascularized uterine myomas with their histopathological diagnosis. METHODS: This was a prospective observational study of patients with a preoperative ultrasound diagnosis of a highly vascularized uterine myoma (color score of 3 or 4, according to the Morphological Uterus Sonographic Assessment (MUSA) criteria), characterized by circumferential and intralesional vascular pattern, who underwent myomectomy or hysterectomy. For each patient, ultrasound characteristics were recorded at baseline, including the number of lesions, the size, echogenicity and border regularity of the lesion, presence of cystic areas and shadowing within the myoma, and visualization of the endometrium. Ultrasound features were correlated with the definitive histological diagnosis. Ultrasound features were then compared between malignant and benign lesions. RESULTS: We included 70 patients with highly vascularized uterine myomas on power/color Doppler. Their mean age was 46.5 ± 11.4 years and 13 (18.6%) were postmenopausal. At histological examination, 65 (92.9%) uterine myomas were benign lesions, comprising 32 typical leiomyomas, 29 leiomyoma variants and four adenomyomas. The remaining five (7.1%) uterine myomas were malignant masses, comprising two uterine sarcomas, one leiomyosarcoma, one neuroendocrine tumor and one uterine smooth muscle tumor of uncertain malignant potential (STUMP). The mean age of patients with a malignant lesion was significantly higher than the age of those with a benign lesion (64.8 ± 16.0 vs 42.4 ± 5.1; P < 0.001). Four out of five patients with a malignant lesion were over 45 years old. Ultrasound demonstrated cystic areas within the lesion in 10/32 (31.3%) typical leiomyomas, 16/29 (55.2%) leiomyoma variants, all four adenomyomas and in the cases of STUMP and leiomyosarcoma. Lesion borders were regular in 64/65 (98.5%) benign lesions and 2/5 (40%) malignant lesions (P < 0.05). No significant differences were observed between benign and malignant lesions with respect to echogenicity, presence of shadowing and size. The endometrium was visible in 55/65 women with benign lesions and in 2/5 with malignant lesions (P = 0.03). CONCLUSIONS: Our results showed that ultrasound features of uterine myomas, such as circumferential and intralesional vascularity, cystic areas and lesion borders, are important parameters for differential diagnosis, especially when combined with the patient's age. Such features could be useful to differentiate typical myomas from benign variants and malignant lesions in a preoperative setting and to select patients that may benefit from conservative management rather than surgery. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Russo C, Camilli S, Martire FG, et al. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology. Ultrasound Obstet Gynecol. 2022. PMID: 35018681. doi:10.1002/uog.24855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。